Matrix Metalloproteinases 2 and 9 (Gelatinases a and B) Expression in Malignant Mesothelioma and Benign Pleura

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expression of Matrix Metalloproteinases 2 and 9 in Meningiomas Associated With Different Degrees of Brain Invasiveness and Edema

Journal of Neurosurgery
SurgeryNeurology
2001English

Matrix Metalloproteinases 2 and 9 Work in Concert to Produce Aortic Aneurysms

Journal of Clinical Investigation
Medicine
2002English

Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression

PLoS ONE
Multidisciplinary
2011English

Malignant Mesothelioma of the Pleura With Desmoplastic Histology: A Case Series and Literature Review

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

A Fluorescence Lifetime Spectroscopy Study of Matrix Metalloproteinases-2 and -9 in Human Atherosclerotic Plaque

Journal of Biophotonics
Materials ScienceAstronomyGeneticsMolecular BiologyBiochemistryEngineeringChemistryPhysics
2011English

Assay of Matrix Metalloproteinases Types 1, 2, 3 and 9 in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Involvement of Matrix Metalloproteinases 2 and 9, Tissue Inhibitor of Metalloproteinases and Apoptosis in Tissue Remodelling in the Sheep Placenta

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2000English

Ebp1 Expression in Benign and Malignant Prostate

Cancer Cell International
Cancer ResearchOncologyGenetics
2008English

Matrix Metalloproteinases 2 and 9 in Avocation of Multitudinal Complications in Explicitly to Carcinoma: Review

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy